Abstract

Purpose/Background Women in developing countries face some of the highest rates of cervical cancer in the world. Similarly, human immunodeficiency virus (HIV)-positive women are at much greater risk of cervical cancer than their HIV-negative counterparts. A cervical cancer screening program for HIV-positive African women was designed to address the intersection of these two public health concerns. Objective To implement a cervical cancer screening program for women receiving HIV care in a Nairobi clinic, as per guidelines outlined in previously conducted needs assessment. Methods Develop infrastructure clinic-wide to support a sustainable program, including training staff, acquiring necessary medical supplies and patient education materials, creating clinic forms and data tracking systems, and establishing a protocol for ongoing management of abnormal results. Results/Conclusions A cervical cancer screening program was established to screen HIV-positive women with an initial target patient population defined as women aged 30 to 39 who were currently on ARV therapy (approximately 550 women). Clinicians counseled and referred patients to a Pap smear procedure clinic conducted by nurses. Slides were read by an on-site pathologist with an estimated turnaround time of 1 week. Clinicians informed patients of results at follow-up appointments and made referrals to the national hospital for additional diagnostics and treatment as indicated. A special fund was established at the national hospital to subsidize care for patients referred from the program. Program monitoring and evaluation are ongoing.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call